Published in Radiother Oncol on July 09, 2009
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiat Oncol (2011) 1.39
Initial experience of hypofractionated radiation retreatment with true beam and flattening filter free beam in selected case reports of recurrent nasopharyngeal carcinoma. Rep Pract Oncol Radiother (2012) 0.99
Unflattened photon beams from the standard flattening filter free accelerators for radiotherapy: Advantages, limitations and challenges. J Med Phys (2011) 0.94
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients. Radiat Oncol (2012) 0.94
An end-to-end examination of geometric accuracy of IGRT using a new digital accelerator equipped with onboard imaging system. Phys Med Biol (2012) 0.84
Safety of high-dose-rate stereotactic body radiotherapy. Radiat Oncol (2015) 0.80
A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer? J Med Radiat Sci (2015) 0.79
Acceptance criteria for flattening filter-free photon beam from standard medical electron linear accelerator: AERB task group recommendations. J Med Phys (2014) 0.78
Surface dose measurements and comparison of unflattened and flattened photon beams. J Med Phys (2016) 0.78
Re-irradiating spinal column metastases using IMRT and VMAT with and without flattening filter - a treatment planning study. Radiat Oncol (2016) 0.77
Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer. Br J Radiol (2015) 0.75
Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution. Radiat Oncol (2016) 0.75
Simultaneous integrated boost (SIB) radiation therapy of right sided breast cancer with and without flattening filter - A treatment planning study. Radiat Oncol (2016) 0.75
Precise film dosimetry for stereotactic radiosurgery and stereotactic body radiotherapy quality assurance using Gafchromic™ EBT3 films. Radiat Oncol (2016) 0.75
Structural Shielding Design of a 6 MV Flattening Filter Free Linear Accelerator: Indian Scenario. J Med Phys (2017) 0.75
Technical Report: Evaluation of peripheral dose for flattening filter free photon beams. Med Phys (2016) 0.75
Dosimetric influence of filtered and flattening filter free photon beam on rapid arc (RA) radiotherapy planning in case of cervix carcinoma. Rep Pract Oncol Radiother (2016) 0.75
Fidelity of dose delivery at high dose rate of volumetric modulated arc therapy in a truebeam linac with flattening filter free beams. J Med Phys (2012) 0.75
Dosimetric comparison of intensity-modulated radiation therapy and volumetric-modulated arc therapy plans for the treatment of glioma using flattening filter-free and flattening filter modes. Oncol Lett (2017) 0.75
Analysis of physical parameters and determination of inflection point for Flattening Filter Free beams in medical linear accelerator. Rep Pract Oncol Radiother (2014) 0.75
Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results. Radiol Med (2017) 0.75
Beam Characterization of 10-MV Photon Beam from Medical Linear Accelerator without Flattening Filter. J Med Phys (2017) 0.75
Comparison of surface dose delivered by 7 MV-unflattened and 6 MV-flattened photon beams. Rep Pract Oncol Radiother (2017) 0.75
A Monte Carlo Study of the Photon Spectrum due to the Different Materials Used in the Construction of Flattening Filters of LINAC. Comput Math Methods Med (2017) 0.75
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol (2011) 2.85
Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys (2011) 2.48
Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2010) 2.05
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2005) 1.86
Current status and future perspective of flattening filter free photon beams. Med Phys (2011) 1.86
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys (2006) 1.75
On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol (2007) 1.64
The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol (2009) 1.48
Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2004) 1.33
Flattening filter free beams in SBRT and IMRT: dosimetric assessment of peripheral doses. Z Med Phys (2010) 1.30
Rotational IMRT techniques compared to fixed gantry IMRT and tomotherapy: multi-institutional planning study for head-and-neck cases. Radiat Oncol (2011) 1.25
Dose-response characteristics of an amorphous silicon EPID. Med Phys (2005) 1.24
Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys (2007) 1.19
Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol (2009) 1.19
Dosimetric characterization of GafChromic EBT film and its implication on film dosimetry quality assurance. Phys Med Biol (2007) 1.18
Insight into trade-off between wood decay and parasitism from the genome of a fungal forest pathogen. New Phytol (2012) 1.17
Stochastic rank correlation: a robust merit function for 2D/3D registration of image data obtained at different energies. Med Phys (2009) 1.12
Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol (2010) 1.11
Interpretation and evaluation of the gamma index and the gamma index angle for the verification of IMRT hybrid plans. Phys Med Biol (2005) 1.11
Radiation Oncology Safety Information System (ROSIS)--profiles of participants and the first 1074 incident reports. Radiother Oncol (2010) 1.09
Feasibility of CBCT-based dose calculation: comparative analysis of HU adjustment techniques. Radiother Oncol (2012) 1.09
Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol (2005) 1.08
Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol (2010) 1.06
IMRT treatment planning:- a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group. Radiother Oncol (2005) 1.06
Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. Radiother Oncol (2006) 1.05
Monitoring tumor motion by real time 2D/3D registration during radiotherapy. Radiother Oncol (2011) 1.03
In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations. Radiother Oncol (2005) 1.02
The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques. Acta Oncol (2009) 1.02
A Monte Carlo study of a flattening filter-free linear accelerator verified with measurements. Phys Med Biol (2010) 1.01
Registration of DRRs and portal images for verification of stereotactic body radiotherapy: a feasibility study in lung cancer treatment. Phys Med Biol (2007) 1.01
Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol (2006) 1.00
Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Int J Radiat Oncol Biol Phys (2005) 0.99
New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame. Radiother Oncol (2009) 0.99
Increased mitochondrial mass in cells with functionally compromised mitochondria after exposure to both direct gamma radiation and bystander factors. Radiat Res (2007) 0.99
PET based volume segmentation with emphasis on the iterative TrueX algorithm. Z Med Phys (2011) 0.99
Advanced kernel methods vs. Monte Carlo-based dose calculation for high energy photon beams. Radiother Oncol (2009) 0.96
Application of commercial MOSFET detectors for in vivo dosimetry in the therapeutic x-ray range from 80 kV to 250 kV. Phys Med Biol (2005) 0.96
Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability. Int J Radiat Oncol Biol Phys (2011) 0.96
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol (2006) 0.95
Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach. Strahlenther Onkol (2005) 0.95
IGRT induced dose burden for a variety of imaging protocols at two different anatomical sites. Radiother Oncol (2011) 0.93
Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations. Phys Med Biol (2003) 0.93
LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience. Radiother Oncol (2003) 0.92
Photon beam quality variations of a flattening filter free linear accelerator. Med Phys (2010) 0.91
Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol (2007) 0.91
Experimental investigation of the response of an a-Si EPID to an unflattened photon beam from an Elekta Precise linear accelerator. Med Phys (2009) 0.89
Development and application of a real-time monitoring and feedback system for deep inspiration breath hold based on external marker tracking. Med Phys (2006) 0.89
Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol (2010) 0.89
Image quality and stability of image-guided radiotherapy (IGRT) devices: A comparative study. Radiother Oncol (2009) 0.89
Radiation therapy with unflattened photon beams: dosimetric accuracy of advanced dose calculation algorithms. Radiother Oncol (2011) 0.88
Dosimetric comparison of stereotactic body radiotherapy in different respiration conditions: a modeling study. Radiother Oncol (2006) 0.88
Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol (2008) 0.88
Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol (2011) 0.88
Experimental verification of a commercial Monte Carlo-based dose calculation module for high-energy photon beams. Phys Med Biol (2009) 0.87
Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator. Strahlenther Onkol (2008) 0.86
Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol (2010) 0.86
Evaluation of treatment plan quality of IMRT and VMAT with and without flattening filter using Pareto optimal fronts. Radiother Oncol (2013) 0.86
A genome-wide association study identifies genomic regions for virulence in the non-model organism Heterobasidion annosum s.s. PLoS One (2013) 0.86
Experimental determination of peripheral photon dose components for different IMRT techniques and linear accelerators. Z Med Phys (2009) 0.85
Modulation of radiation responses by pre-exposure to irradiated cell conditioned medium. Radiat Res (2007) 0.84
A methodology for TLD postal dosimetry audit of high-energy radiotherapy photon beams in non-reference conditions. Radiother Oncol (2007) 0.84
The release of bystander factor(s) from tissue explant cultures of rainbow trout (Onchorhynchus mykiss) after exposure to gamma radiation. Radiat Res (2006) 0.84
Real-time 2D/3D registration using kV-MV image pairs for tumor motion tracking in image guided radiotherapy. Acta Oncol (2013) 0.83
Gene expression and enzyme activity of mitochondrial proteins in irradiated rainbow trout (Oncorhynchus mykiss, Walbaum) tissues in vitro. Radiat Res (2009) 0.82
A noninvasive eye fixation and computer-aided eye monitoring system for linear accelerator-based stereotactic radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys (2003) 0.82
Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm. Strahlenther Onkol (2011) 0.82
A pencil beam algorithm for helium ion beam therapy. Med Phys (2012) 0.82
Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys (2005) 0.81
Comparison of the ESTRO formalism for monitor unit calculation with a Clarkson based algorithm of a treatment planning system and a traditional "full-scatter" methodology. Z Med Phys (2005) 0.81
Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys (2010) 0.81
An intercomparison of 11 amorphous silicon EPIDs of the same type: implications for portal dosimetry. Phys Med Biol (2006) 0.80
Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys (2007) 0.80
Influence of initial electron beam characteristics on monte carlo calculated absorbed dose distributions for linear accelerator electron beams. Phys Med Biol (2002) 0.80
Reactive oxygen species-induced release of signalling factors in irradiated cells triggers membrane signalling and calcium influx in bystander cells. Int J Radiat Biol (2011) 0.80
Altered mitochondrial function and genome frequency post exposure to γ-radiation and bystander factors. Int J Radiat Biol (2010) 0.80
ART for head and neck patients: On the difference between VMAT and IMPT. Acta Oncol (2015) 0.80
Robustness of IMPT treatment plans with respect to inter-fractional set-up uncertainties: impact of various beam arrangements for cranial targets. Acta Oncol (2012) 0.80
Prostate and patient intrafraction motion: impact on treatment time-dependent planning margins for patients with endorectal balloon. Int J Radiat Oncol Biol Phys (2013) 0.80
The pathogenic white-rot fungus Heterobasidion parviporum triggers non-specific defence responses in the bark of Norway spruce. Tree Physiol (2011) 0.80
Automatic patient alignment system using 3D ultrasound. Med Phys (2013) 0.79
Conversion of helical tomotherapy plans to step-and-shoot IMRT plans--Pareto front evaluation of plans from a new treatment planning system. Med Phys (2011) 0.79
Bystander signal production and response are independent processes which are cell line dependent. Int J Radiat Biol (2008) 0.79
Control chart analysis of data from a multicenter monitor unit verification study. Radiother Oncol (2012) 0.79
A dosimetric intercomparison of brachytherapy facilities in Ireland, Scotland and the North of England. Radiother Oncol (2004) 0.79
Kilovoltage x-ray dosimetry--an experimental comparison between different dosimetry protocols. Phys Med Biol (2008) 0.78
Monte Carlo study of TLD measurements in air cavities. Phys Med Biol (2003) 0.78
Implementation and validation of portal dosimetry with an amorphous silicon EPID in the energy range from 6 to 25 MV. Phys Med Biol (2007) 0.78
Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy. Brachytherapy (2009) 0.78